Related Experiment Video
Updated: May 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage
Solveig Horstmann1, Christian Zugck, Ulrike Krumsdorf
1From the Department of Neurology (S.H., T.R., R.V.), Department of Cardiology (C.Z., U.K., N.G., S.H.), and Institute of Medical Biometry and Informatics (G.R.), University of Heidelberg, Germany.
Insights
Percutaneous left atrial appendage occlusion (LAAO) is a safe and feasible procedure for patients with atrial fibrillation and prior intracranial hemorrhage. This study found no major complications or strokes during follow-up.
Area of Science:
- Cardiology
- Interventional Cardiology
- Neurology
Background:
- Patients with atrial fibrillation (AF) and a history of intracranial hemorrhage (ICH) face a high risk of stroke and bleeding.
- Anticoagulant therapy, often used for stroke prevention in AF, increases the risk of ICH.
- Left atrial appendage occlusion (LAAO) offers an alternative stroke prevention strategy.
Purpose of the Study:
- To assess the safety and feasibility of percutaneous LAAO in patients with AF and a history of ICH.
- To evaluate the incidence of major periprocedural complications and long-term clinical outcomes.
Main Methods:
- An observational, prospective, single-center study involving 20 patients with AF and prior ICH.
- LAAO was performed using the Amplatzer Cardiac Plug device.
- Patients were monitored for clinical status and complications at regular intervals post-procedure.
Main Results:
- LAAO was successfully performed in all 20 patients without any procedure-related major complications.
- Minor complications included inguinal hematoma, self-limiting asystole, and device-related thrombus formation.
- No ischemic or hemorrhagic strokes occurred during a mean follow-up of 13.6 months.
Conclusions:
- Percutaneous LAAO is a safe and feasible option for stroke prevention in patients with AF and a history of ICH.
- Further investigation in larger, controlled trials is warranted to confirm efficacy and safety compared to other methods.
Objective:
To evaluate the safety and feasibility of percutaneous left atrial appendage occlusion (LAAO) in patients with atrial fibrillation (AF) and previous intracranial hemorrhage (ICH).
Methods:
In an explorative, prospective, single-center, observational study, LAAO was performed in patients with previous ICH and AF using the Amplatzer Cardiac Plug device. Risks of ischemic strokes and hemorrhagic complications were estimated using the CHA2DS2Vasc score and the HAS-BLED score. Before and 1, 6, 12, and 24 months after the procedure, clinical status and complications were recorded. Major complications were predefined as periprocedural stroke, death, pericardial effusion, and device embolism.
Results:
LAAO was performed in 20 patients. Based on CHA2DS2Vasc score (mean 4.5 ± 1.4) and HAS-BLED score (mean 4.7 ± 1.0), annual risks of stroke and hemorrhagic complications were 4.0%-6.7% and 8.7%-12.5%, respectively. No patient had a procedure-related complication. Minor postprocedural complications were observed in 4/20 patients (2 inguinal hematoma, 1 self-limiting asystole, and 1 thrombus formation on device). No ischemic or hemorrhagic stroke occurred during a mean follow-up of 13.6 ± 8.2 months.
Conclusions:
In this first study of LAAO in patients with previous ICH, LAAO appears feasible and safe. A larger, controlled trial is needed to assess the efficacy and safety of the procedure compared to other preventive measures.
Classification Of Evidence:
This study provides Class III evidence that in patients with a history of previous ICH and AF, percutaneous LAAO is safe and feasible.
Related Concept Videos
Aneurysm III: Interprofessional Care
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

